Obagi OTC kit pairs sunscreen filters with topical skin care products
The DailyMed label for OBAGI MEDICAL BACK TO BASICS identifies a human OTC drug kit centered on sun protection and companion topical skin care products. The kit includes homosalate 10%, octisalate 5%, and zinc oxide 16.5% as the active sunscreen ingredients, with labeling updated on November 9, 2026. Packaged by Obagi Cosmeceuticals LLC, the product sits at the intersection of regulated OTC sunscreen labeling and branded skin care, where consumer expectations often blur the line between pharmacologic protection and cosmetic routine.
The active ingredient profile is clinically familiar. Homosalate and octisalate are organic UV filters used to absorb ultraviolet radiation, while zinc oxide provides a mineral barrier that reflects and scatters UV rays. In practical terms, the combination is designed to reduce the biologic injury that follows chronic and acute sun exposure: erythema, photodamage, and the cumulative risk signals tied to skin cancer and premature aging. The label’s stated use aligns with that mechanism by specifying sunburn prevention and, when used with other sun protection measures, a decrease in the risk of skin cancer and early skin aging caused by the sun.
A sunscreen label lives or dies on its directions, and this one is explicit. Application is directed 15 minutes before sun exposure, with reapplication at least every two hours. Water resistance is recommended during swimming or sweating, and the label calls for broader sun avoidance strategies, including limiting time in the sun between 10 a.m. and 2 p.m. and wearing long sleeves, pants, hats, and sunglasses. Those instructions are not decorative language; they reflect the reality that no topical product fully neutralizes ultraviolet dose when exposure is prolonged or repeated.
One line in the warning section carries immediate bedside relevance: for external use only.
The safety language is standard for topical sunscreen products, but the details matter. The label instructs users not to apply the product to damaged or broken skin, to stop use and ask a doctor if rash occurs, and to avoid the eyes, rinsing with water if contact happens. It also advises keeping the product out of reach of children and seeking medical help or contacting a poison control center if swallowed. For children under 6 months, the instruction is to ask a doctor before use. Those warnings frame the product as a preventive topical agent rather than a benign cosmetic accessory, especially when applied near sensitive skin or in pediatric use.
The kit designation broadens the story beyond sunscreen alone. The package includes multiple topical components, among them OBAGI NU-DERM FOAMING cleansing gel, OBAGI NU-DERM TONER, and OBAGI MEDICAL PROFESSIONAL-C SERUM 20. Each is a leave-on or cleansing skin care product with its own ingredient set, and the listing makes clear that the overall package is a bundled regimen rather than a single drug product. That matters because the consumer is not just buying UV protection; the label anchors a broader regimen that combines sunscreen with facial skin care products intended for topical use on the face and neck.
The ingredient lists reveal a formulation strategy built around moisturizers, surfactants, botanical extracts, preservatives, and fragrance-related components. The sunscreen base itself contains water, C15-19 alkane, octyldodecyl neopentanoate, polymethylsilsesquioxane, sorbitan olivate, silica, glycerin, and dimethicone, among others. The presence of emollients and film-forming agents suggests attention to texture, spreadability, and cosmetic feel, which can influence adherence more than potency alone. In real-world sunscreen use, a formula that patients tolerate is more likely to be applied in adequate quantity and reapplied often enough to matter.
The companion cleanser and toner contain a long list of botanicals and fragrance-associated ingredients, including aloe vera leaf, chamomile, calendula officinalis flower, sage, yucca schidigera root, quillaja saponaria bark, and smilax aristolochiifolia root, alongside preservatives such as parabens, phenoxyethanol, and iodopropynyl butylcarbamate. The toner also lists hamamelis virginiana top water, potassium alum, allantoin, panthenol, and sodium pyrrolidone carboxylate. The serum adds ascorbic acid, ascorbyl glucoside, hyaluronate sodium, zinc chloride, alcohol, and propylene glycol. Even without making claims beyond the label, the mix signals a product line built for cosmetic skin care rather than treatment of a specific disease state.
The labeling also exposes a common tension in dermatologic practice: products marketed as part of a professional routine often contain ingredients that can be useful for skin feel, hydration, or formulation stability, yet also carry irritant or sensitizing potential in susceptible users. Fragrance-related chemicals, surfactants, and certain preservatives can provoke stinging or rash in some individuals, which makes the warning to stop use if rash occurs especially relevant. For patients with sensitive skin, rosacea-prone skin, or a history of contact dermatitis, the ingredient burden may influence tolerability as much as the headline active ingredients do.
Packaging information shows a kit assembled into a single carton and bag, with individual component sizes listed across five parts, including bottles, a dropper, a tube, and another tube. The product is categorized as a HUMAN OTC DRUG with no DEA schedule. The marketing dates span from April 1, 2022 to December 31, 2027. That regulatory framing is straightforward: this is an over-the-counter product line with sunscreen actives and associated cosmetic components, not a prescription dermatology drug.
The label leaves one important clinical question untouched: how the full kit performs in day-to-day use across different skin types, environments, and adherence patterns. The instructions are clear, but the burden of real protection still rests on whether users apply enough product, reapply it on schedule, and combine it with physical sun avoidance measures.